High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancer-Reference-Cited by-同舟云学术

High-dose folinic acid (HDFA) combined with 5-fluorouracil (5-FU) in first line chemotherapy of advanced large bowel cancer

Published:1987-09 Issue:9 Volume:23 Page:1303-1306
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Barone Carlo,Astone Antonio,Garufi Carlo,Grieco Antonio,Cavallaro Antonio,Netri Gaetano,Rossi Simonetta,Cassano Alessandra,Ricevuto Enrico,Noviello Maria R.,Gambassi Gino

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Current concepts in cancer;Moertel,1978

2. Perspectives on the design and biochemical pharmacology of inhibitors of thymidylate synthetase;Santi;J Med Chem,1980

3. Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase;Danenberg;Pharmacol Ther,1983

4. Effect of excess folates and deoxyinosine on activity and site of action of 5-fluorouracil;Evans;Cancer Res,1981

5. The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and alfa-tocopherol;Waxman;Eur J Cancer Clin Oncol,1982

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments

;Pharmacogenomics and Personalized Medicine;2020-11

2. REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM-90 MICROSPHERES;Australian and New Zealand Journal of Surgery;2010-09-06

3. Folinic Acid and 5-Fluorouracil ± Interferon Alfa-2b in the Treatment of Advanced Colorectal Cancer: Preliminary Results of a Randomized Study;Molecular Oncology and Clinical Applications;1993

4. Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Folinic Acid (F), Fluorouracil (FU), Vincristine (O), and Mitomycin-C (Mi), (F-FOMi);American Journal of Clinical Oncology;1992-12

5. Letters to the editor;Annals of Oncology;1992-02